Genetic susceptibility to hydroxychloroquine retinal toxicity.

Area of Science:

• Ophthalmology
• Genetics
• Pharmacology

Background:

• Hydroxychloroquine (HCQ) retinopathy affects up to 7.5% of patients.
• Genetic risk factors for HCQ retinopathy are not well understood.
• This study investigated potential genetic links to HCQ toxicity.

Purpose of the Study:

• To explore candidate genetic risk factors for hydroxychloroquine retinal toxicity.
• To identify specific gene mutations associated with HCQ-induced retinopathy.

Main Methods:

• A case-control study was conducted with 26 Caucasian patients diagnosed with HCQ retinopathy.
• Participants underwent clinical eye exams, optical coherence tomography, visual field testing, and whole exome sequencing.
• Patients were matched with controls based on age, gender, treatment duration, and HCQ indication.

Main Results:

• No specific genetic susceptibility or protective factors were identified in the overall cohort.
• Analysis of 40 candidate genes did not reveal significant associations with HCQ retinopathy.
• No genetic factors were found to be associated with HCQ toxicity in this patient group.

Conclusions:

• The study did not identify genetic risk factors for hydroxychloroquine retinal toxicity.
• Larger studies incorporating whole-exome analysis and additional modifying genes are necessary.
• Further research is needed to elucidate the genetic basis of HCQ retinopathy.